Key points are not available for this paper at this time.
A continuous-flow left ventricular assist device can provide effective hemodynamic support for a period of at least 6 months in patients awaiting heart transplantation, with improved functional status and quality of life. (ClinicalTrials.gov number, NCT00121472 ClinicalTrials.gov.).
Building similarity graph...
Analyzing shared references across papers
Loading...
New England Journal of Medicine
University of Michigan
Columbia University
Massachusetts General Hospital
Add This Paper to Your Research Feed
Any time a new paper drops it will be there.
Miller et al. (Wed,) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: